Hereditary Spastic Paraplegia clinical trials at University of California Health

2 in progress, 1 open to eligible people

Showing trials for

  • Patients With HPDL Mutations

    open to all eligible people

    This study uses medical records that allow retrospective data extraction of clinical manifestation to assess the natural history of HPDL mutations

    at UCSD

  • Phenotype, Genotype & Biomarkers in ALS and Related Disorders

    Sorry, accepting new patients by invitation only

    The goals of this study are: (1) to better understand the relationship between the phenotype and genotype of amyotrophic lateral sclerosis (ALS) and related diseases, including primary lateral sclerosis (PLS), hereditary spastic paraplegia (HSP), progressive muscular atrophy (PMA), and frontotemporal dementia (FTD); and (2) to develop biomarkers that might be useful in aiding therapy development for this group of disorders.

    at UCSD

Our lead scientists for Hereditary Spastic Paraplegia research studies include .

Last updated: